Abiopharma

Indivior Notification

(90% Positive) CULLINAN THERAPEUTICS, INC. (CGEM) Announces Enrollment Update for dosing Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(90% Positive) Opus Genetics, Inc. (OCUP) Announces Enrollment Update for qualify Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(80% Positive) Invivyd, Inc. (IVVD) Announces Enrollment Update for preparing Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(10% Negative) Standard BioTools Inc. (LAB) Announces Business Combination

(90% Positive) VANDA PHARMACEUTICALS INC. (VNDA) Provides Update on effectiveness for Jet Lag DisorderJanuary 8

(90% Positive) CLIMB BIO, INC. (ELYM) Announces Enrollment Update for trial Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Canopy Growth Communication - Canopy Growth Announces Strategic Recapitalization Transactions Significantly Strengthening Balance Sheet to Support Growth Strategy

(90% Positive) AMARIN CORP PLC\UK (AMRN) Provides Update on meetings for our operating expenses

(10% Negative) AMYLYX PHARMACEUTICALS, INC. (AMLX) Files Form 8-K

(10% Negative) Neogen Corporation (NEOG) Reports Q1 2026 Financial Results

Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing

Anika Therapeutics Announces Leadership Transition

Invivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights

Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria